Among all congenital pancreatic anomalies, Dorsal pancreatic agenesis is an extremely rare condition that marks the absence of the tail and body of the pancreas and lacks the duct of Santorini. Despite its various potential clinical manifestations, most patients do not develop overt symptoms, making the diagnosis of dorsal pancreatic absence very difficult. In recent years, this disease has gradually attracted academic attention, but its underlying cause is still unclear, which makes people more curious about it.
Clinical manifestations of dorsal pancreas loss mainly include nonspecific abdominal pain, which often makes early diagnosis difficult.
Most patients with dorsal pancreas loss will not show obvious symptoms, mainly due to the functional reserve of the pancreas. However, patients have reported symptoms such as abdominal pain, weight loss, and jaundice. The location of abdominal pain is concentrated in the upper abdomen and is more obvious after meals, which may be related to pancreatitis or diabetic autonomic neuropathy. These nonspecific symptoms make diagnosis challenging for doctors.
With the advancement of medical technology, the number of diagnostic methods for dorsal pancreas loss has gradually increased. Modern imaging techniques, including endoscopic retrograde cholangiopancreatography (ERCP), magnetic resonance cholangiopancreatography (MRCP), and computed tomography (CT), can all be used in combination for accurate diagnosis.
ERCP, as the diagnostic gold standard, can effectively show the presence or absence of the pancreatic duct, thereby helping to confirm whether there is dorsal pancreatic absence.
Although there is currently no definite cause, some scholars speculate that it may be related to gene regulation of pancreatic development. According to research, the development of the pancreas depends on the interaction of multiple transcription factors, such as Pax4 and Pax6.
Studies have linked the absence of the dorsal pancreas to a variety of other pancreatic diseases, including pancreatitis, diabetes, and different types of pancreatic tumors (such as solid pseudopapillary tumor and adenocarcinoma). Because the body and tail of the pancreas are missing, the beta cells involved in insulin production are affected, which explains why many patients also develop symptoms of diabetes.
Since it was first reported in 1911, the absence of dorsal pancreas has become a long-standing issue in the medical community, with only about 100 cases confirmed so far.
Because most patients with dorsal pancreas loss are asymptomatic at the time of diagnosis, they do not require specific drug treatment. For the accompanying symptoms, doctors usually recommend patients to use pancreatic enzyme capsules and exogenous insulin to improve their quality of life.
For patients with exocrine pancreatic insufficiency, oral supplementation of pancreatic enzymes can effectively improve their symptoms.
In current research related to the absence of dorsal pancreas, scientists have begun to explore its genetic background and development process in order to find more answers to this rare disease. This may be important for a deeper understanding of its mechanisms and potential treatments.
While exploring the rare condition of missing dorsal pancreas, we may want to think about how many diseases there are that are not understood in medicine, waiting for people to unveil their mysteries?